Batavia Biosciences

Batavia Biosciences operates two independent locations of BSL-II/ ML-II R&D and GMP facilities for process development and manufacturing of research material, cell line development, cell and virus banking and the manufacture of drug substance and drug product.

1.      The facility in Leiden consists of R&D labs, a BSL-III polio facility and class C GMP facility. The facility is currently equipped to run up to 20L mammalian processes or 20 L microbial fermentation processes.

2.      The facility in Woburn, MA consists of separate viral vector and recombinant protein/antibodies suites. The facility is equipped to run up to 5L mammalian processes.

3.      Batavia Biosciences manufactures Master Cell banks/ Working Cell Banks & Master Virus Seeds/ Working Virus Seeds. The company also offers clinical production and release of proteins, antibodies, viral vaccines and viral vectors produced in diverse formats (iCELLis, scale-X, WAVE Bioreactors, stainless steel bioreactors, spinner flasks, shake flasks, etc).

Is this your Organization?   Request Access

Locations


Netherlands
Bioscience Park Leiden
Zernikedreef 16
Leiden,   2333 Cl
Netherlands, Europe

GMP Experience
The facility in Leiden consists of R&D labs, a BSL-III polio facility and class C GMP facility. The facility is currently equipped to run up to 200 L mammalian processes or 20 L microbial fermentation
United States
Woburn US
300 TradeCenter
Woburn, MA  01801
United States, North America

GMP Experience
The facility in Woburn, MA consists of separate viral vector and recombinant protein/antibodies suites. The facility is equipped to run up to 50 L mammalian processes.

Contacts


More Information

Production Lines

Bioscience Park Leiden   Microbial Platforms
Location: Leiden, Netherlands
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  MicrobialMicrobial
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  1L-100L20L Bioreactor
GMP Level:  Phase I/IIPhase I/II
Biosafety Level:  Biosafety Level 2Biosafety Level 2
Single Use:  AllAll
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 18JUN14

Send Inquiry about this Production Line
Bioscience Park Leiden   Mammalian Cell Platform
Location: Leiden, Netherlands
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  100L-2000L200L Bioreactor
GMP Level:  Phase I/IIPhase I/II
Biosafety Level:  Biosafety Level 2Biosafety Level 2
Single Use:  AllAll
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 18JUN14

Send Inquiry about this Production Line

Copyright © Kymanox, All Rights Reserved.